创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

司亚璇, 杨勇. 肿瘤浸润性T细胞的代谢调控及干预策略研究进展[J]. 药学进展, 2023, 47(1): 56-65. DOI: 10.20053/j.issn1001-5094.2023.01.006
引用本文: 司亚璇, 杨勇. 肿瘤浸润性T细胞的代谢调控及干预策略研究进展[J]. 药学进展, 2023, 47(1): 56-65. DOI: 10.20053/j.issn1001-5094.2023.01.006
SI Yaxuan, YANG Yong. Metabolic Regulation and Intervention Strategies of Tumor Infiltrating T Cells[J]. Progress in Pharmaceutical Sciences, 2023, 47(1): 56-65. DOI: 10.20053/j.issn1001-5094.2023.01.006
Citation: SI Yaxuan, YANG Yong. Metabolic Regulation and Intervention Strategies of Tumor Infiltrating T Cells[J]. Progress in Pharmaceutical Sciences, 2023, 47(1): 56-65. DOI: 10.20053/j.issn1001-5094.2023.01.006

肿瘤浸润性T细胞的代谢调控及干预策略研究进展

Metabolic Regulation and Intervention Strategies of Tumor Infiltrating T Cells

  • 摘要: T细胞参与并维持免疫应答、免疫自稳态过程,肿瘤浸润性T细胞的功能和状态与抗肿瘤免疫密切相关。在肿瘤微环境(TME)中,T细胞抗肿瘤作用的发挥受到多重限制:TME的物理屏障阻止T细胞浸润;肿瘤细胞为满足其迅速增殖的需求使用有氧糖酵解的方式消耗大量葡萄糖,限制效应T细胞的功能;抑制性免疫细胞和肿瘤细胞的代谢产物大量堆积,改造TME,TME缺氧、营养匮乏、酸化、代谢物大量堆积,影响T细胞的正常代谢,损害其抗肿瘤能力。通过对肿瘤浸润性T细胞代谢的研究,以及靶向TME代谢的治疗策略进行综述,希望能为肿瘤免疫治疗提供新思路。

     

    Abstract: T cells play critical roles in immune response and immune homeostasis. The function and state of tumor-infiltrating T cells are closely related to anti-tumor immunity. In the tumor microenvironment (TME), the anti-tumor effect of T cells is restricted by multiple factors, including the physical barrier of tumor microenvironment preventing T cell infiltration, consumption of large amount of glucose by the tumor cells to meet the needs of rapid proliferation and limiting the function of effector T cells, accumulation of the intermediate metabolites of inhibitory immune cells and tumor cells, and modification of the TME. Hypoxia, nutrient deficiency, acidification and massive accumulation of metabolites in TME affect the normal metabolism of T cells and impair their anti-tumor ability. This paper reviews the research on tumor-infiltrating T cell metabolism and the therapeutic strategies targeting tumor microenvironment metabolism, in the hope of providing some new insight for tumor immunotherapy.

     

/

返回文章
返回